Abstract
AimsIn recent years, patients with programmed cell death-Ligand 1 (PD-L1)-positive oesophageal squamous cell carcinoma (OSCC) have been able to benefit from immunotherapy. However, method for improving the treatment efficacy of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have